Interestingly, we have very recently shown that deficiency in PGC1-alpha leads to hasten disease progression in the males of a mouse model of ALS (Eschbach et al., 2013), strengthening the relation between lipid metabolism alterations and disease progression, at least in SOD1 mice. Here, SOD1 is linked to amyotrophic lateral sclerosis.